Germanywww.biontech.com
BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases.
Through the GEO Score system, we have measured BioNTech's search visibility on the all AI platforms model.Current GEO Score is 95.0.
Reporting Period：03/02/2026 to 03/02/2026
Audit Keyword：BioNTech
95.0
/ 100
Excellent
Dimension Data Details
Share of Model (SOM)(35%)
100BioNTech's Share of Model (SOM) is 100, higher than 20.0% of competitors
Ranking(25%)
78BioNTech's Ranking is 78, higher than 30.0% of competitors
Sentiment(20%)
100BioNTech's Sentiment is 100, higher than 15.0% of competitors
Accuracy(10%)
100BioNTech's Accuracy is 100, higher than 5.0% of competitors
Citation(10%)
100BioNTech's Citation is 100, higher than 95.0% of competitors
Share of Voice (SoV)
Your brand's voice share compared to competitors in AI search
Improvement Opportunities
Your brand outperforms competitor averages across all dimensions
Competitor Comparison
| Brand | GEO Score | SOM | Ranking | Citation | Sentiment | Accuracy | View |
|---|---|---|---|---|---|---|---|
| Moderna | 99.0 | 100.0 | 95.0 | 100.0 | 100.0 | 100.0 | View |
| BioNTech(Current) | 95.0 | 100.0 | 78.0 | 100.0 | 100.0 | 100.0 | |
| Pfizer | 94.0 | 100.0 | 100.0 | 70.0 | 100.0 | 100.0 | View |
| Roche | 94.0 | 100.0 | 93.0 | 80.0 | 100.0 | 100.0 | View |
| AbbVie | 94.0 | 100.0 | 100.0 | 70.0 | 100.0 | 100.0 | View |
| WAI YUEN TONG | 94.0 | 100.0 | 100.0 | 70.0 | 100.0 | 100.0 | View |
BioNTech(Current)
95.0SOM
100.0
Rank
78.0
Cite
100.0
Sent
100.0
Acc
100.0